Comparing Callitas Health (OTCMKTS:MPHMF) & Chesapeake Energy (OTCMKTS:CHK)

Chesapeake Energy (NYSE:CHK) and Callitas Health (OTCMKTS:MPHMF) are both oils/energy companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability.

Analyst Ratings

This is a summary of recent recommendations for Chesapeake Energy and Callitas Health, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Chesapeake Energy 7 8 1 0 1.63
Callitas Health 0 0 0 0 N/A

Chesapeake Energy currently has a consensus price target of $2.57, indicating a potential upside of 324.55%. Given Chesapeake Energy’s higher probable upside, analysts clearly believe Chesapeake Energy is more favorable than Callitas Health.

Profitability

This table compares Chesapeake Energy and Callitas Health’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Chesapeake Energy 5.46% 9.01% 1.03%
Callitas Health N/A N/A N/A

Earnings & Valuation

This table compares Chesapeake Energy and Callitas Health’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Chesapeake Energy $10.23 billion 0.12 $873.00 million $0.90 0.67
Callitas Health N/A N/A N/A N/A N/A

Chesapeake Energy has higher revenue and earnings than Callitas Health.

Risk and Volatility

Chesapeake Energy has a beta of 2.27, indicating that its stock price is 127% more volatile than the S&P 500. Comparatively, Callitas Health has a beta of 0.02, indicating that its stock price is 98% less volatile than the S&P 500.

Insider & Institutional Ownership

69.7% of Chesapeake Energy shares are held by institutional investors. 1.9% of Chesapeake Energy shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Chesapeake Energy beats Callitas Health on 9 of the 9 factors compared between the two stocks.

About Chesapeake Energy

Chesapeake Energy Corporation engages in the acquisition, exploration, and development of properties for the production of oil, natural gas, and natural gas liquids (NGL) from underground reservoirs in the United States. The company holds interests in natural gas resource plays, including the Marcellus in Northern Appalachian Basin in Pennsylvania; Haynesville located in Northwestern Louisiana; Eagle Ford in South Texas; Brazos Valley in Southeast Texas; Powder River Basin in Wyoming; and Mid-Continent in Anadarko Basin of northwestern Oklahoma. As of December 31, 2018, it owned interests in approximately 13,200 oil and natural gas wells; and had estimated proved reserves of 1,448 one million barrels of oil equivalent. Chesapeake Energy Corporation was founded in 1989 and is headquartered in Oklahoma City, Oklahoma.

About Callitas Health

Callitas Health, Inc. is a clinical stage company. It engages in the development of technologies for obesity, weight management, and female health and wellness. The company focuses on developing technologies for weight management, female sexual health and wellness, cannabis delivery technologies and other proprietary drugs. It launched product ToConceive in North America. The firm researches, develops and business development processes for its other OTC products, CannaMint strips and orphan drug technologies. Callitas Health was founded on March 11, 2003 and is headquartered in Newport, KY.

Receive News & Ratings for Chesapeake Energy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chesapeake Energy and related companies with MarketBeat.com's FREE daily email newsletter.